Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dr. Emad AB
AB
Active
Org 5593786089
Södra Långebergsgatan 20
Medical specialists activities · NACE 8622
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 855K
+33% vs 2024
EBITDA margin
36.0%
+25% vs 2024
Equity ratio
31.6%
Financial strength
Net profit 2025
SEK 190K
+2% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 855K
+33%
EBITDA
SEK 308K
+25%
Net profit
SEK 190K
+2%
Total assets
SEK 756K
+26%
Equity
SEK 238K
-6%
Employees
0
—
Company information
Legal name
Dr. Emad AB
Org number
5593786089
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 maj 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom vården. Ägaren är läkare och tänker jobba som hyrläkare där det finns ett behov.
Contact
Address
Södra Långebergsgatan 20
Email
emadeddin.md@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
557
643
855
Staff expenses
−16
−109
−307
EBITDA
429
246
308
Depreciation & amort.
−20
−39
−39
EBIT
410
207
269
Net financials
0
6
5
Profit before tax
304
239
253
Tax
−66
−53
−64
Net profit
238
186
190
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
594
598
756
Equity
263
253
238
Long-term debt
—
—
—
Short-term debt
225
265
417
Total debt
225
265
417
Financial ratios
5-year trend
EBITDA margin
36.0%
This company
15.8%
Market median
+128% vs market
2023
2025
Equity ratio
31.6%
This company
38.2%
Market median
+17% vs market
2023
2025
Return on equity
79.5%
This company
18.4%
Market median
+332% vs market
2023
2025
Net profit margin
22.2%
This company
8.1%
Market median
+174% vs market
2023
2025
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
2023
2025
Debt / equity
2.17×
This company
0.62×
Market median
-250% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-03 – 2023-03-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SR
Shahd Ramadan Mohammad Fitiany
Deputy Board Member
2022
IA
Imadeddin Adel Eid Abu Ishkheidem
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dr. Emad AB also hold positions in
0
other companies.
Person
Role here
Other companies
Shahd Ramadan Mohammad Fitiany
Deputy Board Member
0 companies
Imadeddin Adel Eid Abu Ishkheidem
Board of Directors
0 companies